Bright future for all medical device producers and biotech companies
Global to reach $109.5billion by 2027 – U.S. Market is estimated at $16B.
Class I, one of the segments analyzed in the report, is projected to record a 8.7% CAGR and reach US$36.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Class II segment is readjusted to a revised 9.7% CAGR for the next 7-year period.
Class III Segment to Record 8.8% CAGR
In the global Class III segment, USA, Canada, Japan, China and Europe will drive the 8.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$10.6 Billion in the year 2020 will reach a projected size of US$18.5 Billion by the close of the analysis period.
